Ankle Sprain
5
Pipeline Programs
4
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
1
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
SandozAustria - Kundl
3 programs1
1
1
diclofenac potassium 25 mg tabletPhase 4
Diclofenac sodium topical gel 1%Phase 3
Diclofenac diethylamine 2.32% gelPhase 2
Teikoku SeiyakuJapan - Higashikagawa
1 program1
Esflurbiprofen Hydrogel PatchPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Teikoku SeiyakuEsflurbiprofen Hydrogel Patch
Colorado TherapeuticsSemiconductor Embedded Sock
Clinical Trials (2)
Total enrollment: 106 patients across 2 trials
Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain
Start: Jul 2016Est. completion: Dec 20166 patients
Phase 2Terminated
Semiconductor Embedded Socks for Ankle Sprains
Start: Apr 2025Est. completion: Dec 2027100 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 106 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.